Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 2125 of 3033 entries
View as:

Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting

Phase: N/A Priority: Normal
NCT ID: NCT01610063 Org: User:
Start: 01/31/09 End: 05/31/13 Due: 05/31/14

Sonography of the Nipple Areolar Complex

Phase: N/A Priority: Normal
NCT ID: NCT06441188 Org: User:
Start: 09/10/24 End: 10/08/24 Due: 10/08/25

Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements

Phase: N/A Priority: Normal
NCT ID: NCT06431295 Org: User:
Start: 10/01/25 End: 06/30/28 Due: 06/30/29

TAS-102 in Treating Advanced Biliary Tract Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03278106 Org: User:
Start: 10/20/17 End: 09/16/21 Due: 09/16/22

Registry of Patients Prescribed Anticoagulation

Phase: N/A Priority: Normal
NCT ID: NCT03504007 Org: User:
Start: 03/01/13 End: 03/31/33 Due: 03/31/34

Phase I/II Cancer Caregiver Interventions to Improve Quality of Life and Prevent Burnout

Phase: N/A Priority: Normal
NCT ID: NCT02166866 Org: User:
Start: 09/09/13 End: 06/27/18 Due: 06/27/19

Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction

Phase: N/A Priority: Normal
NCT ID: NCT00392379 Org: User:
Start: 01/31/07 End: 03/31/09 Due: 03/31/10

Wound Closure Study in Carpal Tunnel and Trigger Finger Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03781141 Org: User:
Start: 12/01/19 End: 01/31/26 Due: 01/31/27

Cluster Headache Treatment With Rimegepant

Phase: N/A Priority: Normal
NCT ID: NCT05264714 Org: User:
Start: 09/07/22 End: 12/31/25 Due: 12/31/26

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05557877 Org: User:
Start: 03/09/23 End: 01/30/27 Due: 01/30/28

Daratumumab to Treat Active Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT04868838 Org: User:
Start: 04/20/21 End: 07/31/26 Due: 07/31/27

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Phase: N/A Priority: Normal
NCT ID: NCT06764095 Org: User:
Start: 01/08/25 End: 12/31/34 Due: 12/31/35

Endoprosthesis Metal Toxicity Study

Phase: N/A Priority: Normal
NCT ID: NCT04755140 Org: User:
Start: 03/19/21 End: 05/01/24 Due: 05/01/25

Bandage Contact Lens Application for the Management of Corneal Abrasion

Phase: N/A Priority: Normal
NCT ID: NCT04159714 Org: User:
Start: 09/10/19 End: 10/24/19 Due: 10/24/20

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Phase: N/A Priority: Normal
NCT ID: NCT05075980 Org: User:
Start: 02/16/22 End: 11/15/26 Due: 11/15/27

Early Diuresis Following Colorectal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02351934 Org: User:
Start: 02/28/15 End: 04/30/16 Due: 04/30/17

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06667726 Org: User:
Start: 09/08/25 End: 10/08/29 Due: 10/08/30

Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform

Phase: N/A Priority: Normal
NCT ID: NCT06349642 Org: User:
Start: 04/24/24 End: 05/31/27 Due: 05/31/28

Insulin Regulation of Lipolysis and Lipolysis Proteins

Phase: N/A Priority: Normal
NCT ID: NCT03866408 Org: User:
Start: 11/12/18 End: 12/31/25 Due: 12/31/26

Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03946618 Org: User:
Start: 01/18/19 End: 02/28/27 Due: 02/28/28

Treating Amblyopia in Adults With Interactive Video Games

Phase: N/A Priority: Normal
NCT ID: NCT03906994 Org: User:
Start: 10/01/19 End: 12/31/21 Due: 12/31/22

Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults

Phase: N/A Priority: Normal
NCT ID: NCT03524521 Org: User:
Start: 11/06/18 End: 01/08/21 Due: 01/08/22

Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02254239 Org: User:
Start: 02/04/16 End: 12/12/18 Due: 12/12/19

Pilot Study to Evaluate the Contribution of Gene Variants to Idiopathic Urolithiasis

Phase: N/A Priority: Normal
NCT ID: NCT01127854 Org: User:
Start: 12/31/09 End: 12/31/25 Due: 12/31/26

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03418038 Org: User:
Start: 03/23/18 End: 03/31/26 Due: 03/31/27